Matches 1 - 50 out of 219 1 2 3 4 5 >


Match Document Document Title
US20140073611 METHODS FOR DRUG SCREEN USING ZEBRAFISH MODEL AND THE COMPOUNDS SCREENED THEREFROM  
The disclosure relates to a platform of using zebrafish in screening candidates for treating and/or preventing myopia and keratoconus disease. The disclosure is mainly based on that Lumican, one...
US20120282307 GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
US20120064129 GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
US20120219609 PATHOGEN PROTECTION GARMENT WITH BOTH RAPID AND PERSISTENT RECHARGABLE SELF-STERILIZATION  
A moisture-permeable glove or other garment protects against user contamination and cross-contamination by providing both rapid and persistent sterilization. Exposure to halogen of inherent NH...
US20150157558 METHODS OF TREATMENT USING A GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises delivery of gabapentin in a gastric retained dosage form.
US20130129843 Microbiocidal Treatment Of Edible Fruits And Vegetables  
Methods of controlling bacterial, yeast, and/or mold contamination of edible fruits or vegetables comprise applying thereto an aqueous microbiocidal composition formed from water and (A) at least...
US20140024598 METHODS AND COMPOSITIONS FOR PRESERVING RETINAL GANGLION CELLS  
Provided are methods and compositions for maintaining the viability of retinal ganglion cells in a subject with an ocular disorder including, for example, glaucoma and optic nerve injury. The...
US20140206693 COMPOSITIONS AND METHODS FOR TREATING COLON CANCER  
Certain embodiments are directed to methods of treating a pathophysiological state or symptoms thereof resulting from aldose reductase-mediated signaling in a cytotoxic pathway using an aldose...
US20140147691 WOOD PRESERVATIVE FORMULATION  
The present invention relates to a preservative formulation for use in treating wood or other cellulosic materials, said formulation comprising: at least one biocidal metal compound; at least one...
US20150148353 OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES  
A method of increasing the insulin sensitivity of a mammalian cell by contacting the cell with a protein phosphatase 2A (PP2A) inhibitor having the structure:
US20140319059 Method and Kit For Treating Recreational Water  
Provided herein is a method for reducing down-time in a recreational body of water having a water filtering system and water recirculation system after a potential release of Cryptospridium oocyst...
US20060251649 Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate  
Aspects of this invention include the use of G-2MePE to treat patients with brain injury characterized by non-convulsive seizures. G-2MePE is useful in treating brain injuries caused by traumatic...
US20130338116 COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN AND OTHER DISEASES  
The present invention relates generally to pharmaceutical agents, and in particular, to metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of dual...
US20070049630 Method of using ryanodine receptor antagonists to treat amyotrophic lateral sclerosis  
The present invention provides a method of providing neural protection in in human patients suffering from amyotrophic lateral sclerosis comprising administering to said patients suffering from...
US20120115849 Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors  
This disclosure is directed to treatment of addictions and primary impulse-control disorders using phosphodiesterase 7 (PDE7) inhibitors, alone or in combination with other therapeutic agents.
US20060258561 Novel NPH insulin preparations  
This invention relates to NPH-insulin (crystalline preparations) that are prepared in the presence of certain high-affinity ligands for the HisB10 Zn2+-sites of the R-state insulin hexamer....
US20110021587 METHODS OF REDUCING OR ELIMINATING BACTERIA IN CONSUMABLE EGGS  
Methods are provided for reducing or eliminating bacteria such as Salmonella in eggs for human consumption through the use of at least one N,N-dihalo-5,5-dialkylhydantoin in which each of the...
US20110144173 FUNGICAL CONTROL OF MOULDS  
A composition for treating fungus infection of turfgrass, such as snow mould infection, comprises a mixture of fungicidally effective amounts of formulae 1 and 2: and in particular mixtures of...
US20110306601 PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION  
Antagonists of group 1 metabotropic glutamate receptors (mGluR) potentiate the effect of positive AMPA receptor modulators on neurotrophin expression, such as brain-derived neurotrophic factor...
US20060030611 Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases  
The present invention provides the (R)-(+) enoximone sulfoxide enantiomer, as well as pharmaceutical formulations of the purified (R)-(+) sulfoxide enantiomer. Also provided are methods of...
US20060292213 Enoximone formulations and their use in the treatment of PDE-III mediated diseases  
The present invention provides pharmaceutical formulations of the drug enoximone for use in treatment of disease states in which inhibition of PDE-III may be beneficial.
US20090105323 TREATMENT OF EDIBLE CROPS  
In the growing of crops for consumption, a method for the removal of pathogens includes the addition to irrigation water for the crops of an anti-pathogen composition and supplying the...
US20110318308 LIPOCALIN-TYPE PROSTAGLANDIN D2 SYNTHASE AS A BIOMARKER FOR LUNG CANCER PROGRESSION AND PROGNOSIS  
A PGD(2) receptor (DP) deficiency enhances tumor progression accompanied by abnormal vascular expansion. In tumors, angiogenic endothelial cells highly express DP receptor, and its deficiency...
US20150126435 PRIMERS, ASSAYS AND METHODS FOR DETECTING AN E. COLI SUBTYPE  
Disclosed are primers, probes, and single nucleotide polymorphisms (SNP) specific to a distinct subclones of the E. coli sequence type 131 (ST131). Also disclosed are methods and assay kits useful...
US20070066638 RYANODINE RECEPTOR BLOCKERS FOR TREATING PAIN  
The present invention provides a method of preventing or ameliorating pain in a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action causing said...
US20120148651 Articles Having Antimicrobial Properties And Methods of Manufacturing the Same  
According to one embodiment, a coagulant comprising calcium nitrate and an antimicrobial agent is disclosed. The coagulant may be used in the molding process to releasably bond the substrate...
US20110288083 METHOD OF TREATING CANCER BY INHIBITION OF PROTEIN KINASE-LIKE ENDOPLASMIC RETICULUM PROTEIN KINASE  
The present invention relates to a method of identifying compounds useful in inhibiting protein kinase-like endoplasmic reticulum protein kinase (PERK). The method comprises providing a first...
US20050182076 Transdermal penetration system and treatment for cellulite  
The present invention is a powerful vasodilatation and transdermal penetration system, which quickly penetrates the dermis of the skin and deposits beneficial ingredients at the subcutaneous...
US20140137808 STRETCHABLE INSECT REPELLANT BAND  
The present invention is directed to an insect repelling device that may serve as an effective barrier against ticks. The insect repelling device may include a band of technical fabric, with the...
US20090220559 Multifunctional Solid Formulations for Water Conditioning  
Solid formulations for use in water conditioning of circulating reservoirs, processes of preparing same and methods for water conditioning utilizing same are disclosed. The solid formulations...
US20110212994 Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders  
Small molecule choline kinase inhibitors, pharmaceutical compositions thereof, and screening methods for identifying and evaluating choline kinase inhibitors are provided. Safe and effective...
US20090306162 FUNGICIDAL CONTROL OF MOULDS  
A composition for treating fungus infection of turfgrass, such as snow mould infection, comprises a mixture of fungicidally effective amounts of formulae 1 and 2: And in particular mixtures of...
US20100130574 NEURODEGENERATIVE DISEASES AND METHODS OF MODELING  
This invention relates to methods for neuroprotection, promoting survival of motor neurons and the treatment of motor neuron diseases by preventing cell signaling through the classic prostaglandin...
US20080038303 Novel Solid Compositions for Disinfected Water  
The present invention provides a method for the preparation of water-sanitizing solid, shaped compositions, said method comprising the steps of: mixing a halogenated 5,5-dimethylhydantoin compound...
US20060063774 Phosphodiesterase inhibitor compounds and nitric oxide donors  
The invention provides phosphodiesterase inhibitors and/or nitric oxide donors that are useful in treating male impotence, female sexual dysfunction and anal diseases.
US20120277276 TREATMENT OF EDIBLE CROPS  
In the growing of crops for consumption, a method for the removal of pathogens includes the addition to irrigation water for the crops of an anti-pathogen composition and supplying the...
US20110190329 NON-AMIDIC LINKERS WITH BRANCHED TERMINI AS CGRP RECEPTOR ANTAGONISTS  
The present invention is directed to novel non-amidic linkers with branched termini derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in...
US20130109731 ANTIMICROBIAL COMPOSITIONS AND METHODS FOR MAKING SAME  
An antimicrobial composition comprising water, an organic acid such as citric acid, chitosan, and one or more heterocyclic N-halamine compounds such as MDMH and/or DMDMH.
US20050013876 Inactivation of papillomavirus  
A method of treating early papillomavirus infection of an orifice of a human or animal body including any canal associated with an orifice, comprising applying a viral inactivation agent to the...
US20140031341 MODULATORS AND METHODS FOR THE TREATMENT OF ROSACEA  
An in vitro method of screening candidate compounds for the preventive or curative treatment of rosacea is described. The method can include determining the capacity of a compound to modulate the...
US20050215609 Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist  
The present invention provides novel use of PGD2, a PGD2 agonist and a PGD2 antagonist. More specifically, the present invention provides uses of PGD2 and a PGD2 agonist as eating promoter and use...
US20120010181 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS  
This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt, solvate or...
US20080069791 Means for stimulation and activation of hair growth by il-15  
The present invention relates to the use of IL-15 polynucleotides, polypeptides or compounds which bind to an antibody which specifically recognizes the IL-15 polypeptide or which specifically...
US20150132405 SYNERGISTIC COMPOSITIONS OF MONOCHLOROUREA AND MODIFIED MONOCHLOROUREAS  
The present invention provides synergistic combinations of monochlorourea with other biocides for controlling microbial growth in aqueous systems. It also provides synergistic combinations of...
US20140099512 MICROBIAL RESISTANT ROOF COATING AND SYSTEM  
A roofing and/or siding material that reduces the incidence of undesired micro-organisms from entering into the air intake of air conditioner and/or heating systems of a building structure to...
US20070167419 TREATMENT FOR EMBOLIC STROKE  
Provided herein are methods and compositions for treating stroke that include contacting a subject suffering from a stroke with (1) an antioxidant; (2) an antioxidant and one or more of (i) a...
US20120015926 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS  
This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt thereof, which...
US20100063119 SUBSTITUTED CARBINOL COMPOUND  
There is provided a novel LXRβ agonist useful as a preventative and/or therapeutic agent for arteriosclerosis; arteriosclerosis such as those resulting from diabetes; hyperlipidemia;...
US20090076045 Non-nucleoside reverse transcriptase inhibitors  
Compounds of formula I, wherein R1, X1, X2 and A, are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention and...
US20090155385 METHODS OF REDUCING OR ELIMINATING SALMONELLA IN REPTILES AND/OR THEIR EGGS  
A method for reducing or eliminating Salmonella in reptiles and/or reptile eggs through the use of at least one N,N-dihalo-5,5-dialkylhydantoin in which each of the alkyl groups is independently...

Matches 1 - 50 out of 219 1 2 3 4 5 >